Patienter med allerede kendt leverdysfunktion, inklusive kronisk aktiv hepatitis har en øget frekvens af leverfunktionsabnormaliteter under antiretroviral kombinationsterapi og bør monitoreres i henhold til standard praksis.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.